IGF1R and breast cancer: Experiments in ER+ breast cancer cell lines demonstrate that activation of the IGF‐1R signaling pathway is associated with PI3K/MAPK pathway signaling, p‐ERα(Ser167) phosphorylation and cell proliferation in the presence of tamoxifen.